Organic Acidurias 1
The Organic Acidurias 1 session will be discussing MMA (mut, cobalamin A,B,C,D,F,J,X metabolism).
This educational activity is supported by an educational grant from Ultragenyx.
- Recognize clinical manifestations of the hereditary methylmalonic acidemias.
- Explain the underlying disease mechanisms of hereditary methylmalonic acidemias, including the metabolic pathways and biochemical processes involved.
- Evaluate and compare different treatment approaches for hereditary methylmalonic acidemias.
Irini Manoli, MD, PhD
Clinician Associate Investigator
Clinical and Biochemical Genetics
National Institute of Health
Irini Manoli, MD, PhD, speaker for this activity, has received preclinical research funding from Selecta Biosciences, Inc.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance